Prenetics Global Ltd

For the period ended Nov 20, 2025. Filed Nov 20, 2025.

About this filing

What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.

Nov 20, 2025 · Filed Nov 20, 2025

Use the contents to explore the available documents and sections.

PRE$15.94-1.1%Stored close · as of Nov 6, 2026

See the whole filing, with its images and exhibits

Contents

EXPLANATORY NOTE

Prenetics Global Limited (the "Company"), a leading health sciences company and parent of the IM8 premium health and longevity brand, furnishes this Form 6-K to announce that on November 19, 2025 its Chief Executive Officer and co-founder, Danny Sheng Wu Yeung, purchased 20,000 shares of the Company's Class A Ordinary Shares at a price of $13.00 per share in the open market for a total purchase price of $260,000, bringing his total holdings of Class A Ordinary Shares to 96,412.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.